Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387135927> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4387135927 abstract "<h3>Introduction/Background</h3> In FIGO stages IB1-IB2 and IIA1 cervical cancer with suspected cervical stromal ring disruption on preoperative evaluation, radical surgery is indicated even though there is an increased risk of adjuvant chemo-radiotherapy (CCRT). While exclusive CCRT represents the gold standard for FIGO stages IB3/IIA2, subgroup analysis restricted to these stages of studies comparing CCRT vs neoadjuvant chemotherapy (NACT) showed similar outcomes between the two groups. The primary aim of this study is to evaluate the role of dose-dense NACT with carboplatin and paclitaxel in patients with FIGO stage IB1-IB2/IIA1 with preoperative stromal ring disruption or IB3-IIA2. <h3>Methodology</h3> Patients with FIGO stages IB1-IIA2 undergoing dose-dense NACT at the European Institute of Oncology, Milan from 07/2014 to 12/2022 were retrospectively identified. They received weekly dose-dense carboplatin + paclitaxel for 6–9 cycles followed by radical surgery or CCRT, depending on radiologic response as assessed by RECIST criteria. Predictors of radiologic response to NACT and follow-up data were evaluated with appropriate statistical analysis. <h3>Results</h3> A total of 64 patients meeting inclusion criteria were included. Radiological response to NACT were the following: 10(15,6%) complete response, 41(64,0%) partial response, 11(17,0%) stable disease, and 2(3,1%) progressive disease. None of the evaluated factors were associated with radiological response to NACT (table 1). After multidisciplinary team discussion, 6 (9,4%) patients were deemed inoperable and received CCRT. Among the remaining 58 (90,6%) patients undergoing surgery, 14 (24,1%) underwent CCRT, 2 (3,4%) radiotherapy alone, and 7 (12,1%) chemotherapy alone, while the remaining 35 (60,3%) were observed. Overall, NACT followed by surgery allowed us to avoid radiotherapy in 42 (65.6%) patients. Among them, during a median follow-up time of 52 months (range 6–94), 5 (11,3%) patients experienced a recurrence. <h3>Conclusion</h3> Dose-dense NACT achieved a good response rate and could be considered an alternative approach, especially in young patients desiring to avoid radiotherapy. <h3>Disclosures</h3> No conflict of interest for all the authors" @default.
- W4387135927 created "2023-09-29" @default.
- W4387135927 creator A5000468311 @default.
- W4387135927 creator A5000699221 @default.
- W4387135927 creator A5007007404 @default.
- W4387135927 creator A5007699056 @default.
- W4387135927 creator A5013924810 @default.
- W4387135927 creator A5021471647 @default.
- W4387135927 creator A5027564336 @default.
- W4387135927 creator A5029489211 @default.
- W4387135927 creator A5041582365 @default.
- W4387135927 creator A5043789773 @default.
- W4387135927 creator A5045924412 @default.
- W4387135927 creator A5048838073 @default.
- W4387135927 creator A5057690557 @default.
- W4387135927 creator A5064462811 @default.
- W4387135927 creator A5066888430 @default.
- W4387135927 creator A5076421182 @default.
- W4387135927 date "2023-09-01" @default.
- W4387135927 modified "2023-09-29" @default.
- W4387135927 title "#953 Neoadjuvant dose-dense chemotherapy with carboplatin and paclitaxel in FIGO 2018 stage IB1-IIA2 cervical cancer" @default.
- W4387135927 doi "https://doi.org/10.1136/ijgc-2023-esgo.209" @default.
- W4387135927 hasPublicationYear "2023" @default.
- W4387135927 type Work @default.
- W4387135927 citedByCount "0" @default.
- W4387135927 crossrefType "proceedings-article" @default.
- W4387135927 hasAuthorship W4387135927A5000468311 @default.
- W4387135927 hasAuthorship W4387135927A5000699221 @default.
- W4387135927 hasAuthorship W4387135927A5007007404 @default.
- W4387135927 hasAuthorship W4387135927A5007699056 @default.
- W4387135927 hasAuthorship W4387135927A5013924810 @default.
- W4387135927 hasAuthorship W4387135927A5021471647 @default.
- W4387135927 hasAuthorship W4387135927A5027564336 @default.
- W4387135927 hasAuthorship W4387135927A5029489211 @default.
- W4387135927 hasAuthorship W4387135927A5041582365 @default.
- W4387135927 hasAuthorship W4387135927A5043789773 @default.
- W4387135927 hasAuthorship W4387135927A5045924412 @default.
- W4387135927 hasAuthorship W4387135927A5048838073 @default.
- W4387135927 hasAuthorship W4387135927A5057690557 @default.
- W4387135927 hasAuthorship W4387135927A5064462811 @default.
- W4387135927 hasAuthorship W4387135927A5066888430 @default.
- W4387135927 hasAuthorship W4387135927A5076421182 @default.
- W4387135927 hasBestOaLocation W43871359271 @default.
- W4387135927 hasConcept C121608353 @default.
- W4387135927 hasConcept C126322002 @default.
- W4387135927 hasConcept C143998085 @default.
- W4387135927 hasConcept C146357865 @default.
- W4387135927 hasConcept C151730666 @default.
- W4387135927 hasConcept C2776694085 @default.
- W4387135927 hasConcept C2776874909 @default.
- W4387135927 hasConcept C2778220009 @default.
- W4387135927 hasConcept C2778239845 @default.
- W4387135927 hasConcept C2778822529 @default.
- W4387135927 hasConcept C2779984678 @default.
- W4387135927 hasConcept C2781451048 @default.
- W4387135927 hasConcept C71924100 @default.
- W4387135927 hasConcept C86803240 @default.
- W4387135927 hasConceptScore W4387135927C121608353 @default.
- W4387135927 hasConceptScore W4387135927C126322002 @default.
- W4387135927 hasConceptScore W4387135927C143998085 @default.
- W4387135927 hasConceptScore W4387135927C146357865 @default.
- W4387135927 hasConceptScore W4387135927C151730666 @default.
- W4387135927 hasConceptScore W4387135927C2776694085 @default.
- W4387135927 hasConceptScore W4387135927C2776874909 @default.
- W4387135927 hasConceptScore W4387135927C2778220009 @default.
- W4387135927 hasConceptScore W4387135927C2778239845 @default.
- W4387135927 hasConceptScore W4387135927C2778822529 @default.
- W4387135927 hasConceptScore W4387135927C2779984678 @default.
- W4387135927 hasConceptScore W4387135927C2781451048 @default.
- W4387135927 hasConceptScore W4387135927C71924100 @default.
- W4387135927 hasConceptScore W4387135927C86803240 @default.
- W4387135927 hasLocation W43871359271 @default.
- W4387135927 hasOpenAccess W4387135927 @default.
- W4387135927 hasPrimaryLocation W43871359271 @default.
- W4387135927 hasRelatedWork W2053778437 @default.
- W4387135927 hasRelatedWork W2351245677 @default.
- W4387135927 hasRelatedWork W2361489546 @default.
- W4387135927 hasRelatedWork W2370148199 @default.
- W4387135927 hasRelatedWork W2375109685 @default.
- W4387135927 hasRelatedWork W2569260518 @default.
- W4387135927 hasRelatedWork W3002609124 @default.
- W4387135927 hasRelatedWork W3029907145 @default.
- W4387135927 hasRelatedWork W3031735911 @default.
- W4387135927 hasRelatedWork W4285811566 @default.
- W4387135927 isParatext "false" @default.
- W4387135927 isRetracted "false" @default.
- W4387135927 workType "article" @default.